Business Wire

CARGILL

13.3.2024 09:01:38 CET | Business Wire | Press release

Share
Cargill Shares Outcome of the World’s First Wind-Powered Ocean Vessel’s Maiden Voyage

Cargill today revealed exciting results of the six-month test period of the Pyxis Ocean, underscoring the potential for the wind assisted propulsion technology in moving the shipping industry toward renewable energy use. The MC Shipping Kamsarmax vessel retrofitted with two WindWings® -large solid wind sails developed by BAR Technologies - - has achieved performance consistent with what was predicted which is equivalent to an average of 3 tonnes of fuel per day.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313673847/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Pyxis Ocean sailing through the English Channel from Spain to Amsterdam, March 2024 (Photo: Business Wire)

“We are encouraged by the results and have learned a great deal about implementing wind assisted propulsion on dry bulk vessels,” said Jan Dieleman, president of Cargill’s Ocean Transportation business. “We could never have done this alone – BAR Technologies and MC Shipping and have been fantastic partners in making the Pyxis Ocean a reality as well as the captain and crew. We are on the leading edge of change in the shipping industry and believe technologies that harness the wind could be an important, cost-effective way to achieve our decarbonization goals in the short, medium and long-term.”

The Pyxis Ocean hit open waters in August 2023 and during the first six months of testing it has sailed the Indian Ocean, Pacific Ocean, North and South Atlantic, and passed Cape Horn and the Cape of Good Hope. The ship was retrofitted with two WindWings®, which measure 37.5 meters in height and resemble large airplane wings. The wings are installed vertically to catch the wind and propel the ship forward, allowing the ship’s engine to be turned down so that the ship can travel at the same speed as a conventional ship using less fuel. The wings are controlled by a touch panel on the bridge. A simple traffic light system tells the crew when to raise or lower the sails. Once raised, the operation is fully automated: sensors onboard constantly measure the wind, and the sails self-adjust to the optimal configuration.

Wind assisted propulsion has potential to be a cost-efficient way of supporting the International Maritime Organization's (IMO) new greenhouse gas strategy. One of the IMOs 2030 targets is to have 5 percent, striving for 10 percent, of energy coming from very low carbon sources by 2030: wind assisted propulsion could be an important way of achieving this.

The early voyages have provided insight on more than just the application of the sails on a vessel, it has also highlighted broader logistical challenges in the global maritime system. Given that every port, terminal, and berth is different, their involvement is critical towards integrating Wind Assisted Propulsion (WAP) technology into the global maritime system on a wider scale.

John Cooper, BAR Technologies CEO added, “The results of the Pyxis Ocean’s first voyage with WindWings® installed clearly demonstrate that wind assisted propulsion can secure significant fuel savings and emissions reduction. For example, in near optimum sailing conditions, during an open sea voyage, the Pyxis Ocean achieved fuel savings of 11 tonnes per day. And while the Pyxis Ocean has two WindWings®, we anticipate the majority of Kamsarmax vessels will carry three wings, further increasing the fuel savings and emissions reductions by a factor of 1.5. With Cargill we are now able to validate our performance predictions and modelling in real-world conditions, it’s an exciting time as we begin to roll out WindWings® production globally.”

“Cargill is creating ways for all WAP vessels - not just the Pyxis Ocean - to operate on global trade routes,” said Dieleman. “So far, we’ve engaged with more than 250 ports to find ways of enabling vessel with large scale WAP to berth. This complexity is where Cargill truly excels, and how we can leverage our unique role in the maritime industry. We are not afraid to be a development partner and invest, share risks with partners, and to make a difference in transforming the industry.”

Cargill will continue the testing and experimenting of operational, technical and commercial aspects of the Pyxis Ocean to incorporate the maximum amount of learning into potential design of future installations before scaling up.

Notes to editors:

[1]

  • BAR Technolgies and Cargill estimate an annual average savings of 3 tonnes of fuel reductions per day (this equates to 11,2/t/day CO2e well-to-wake emissions reductions. This equates to roughly 14 percent savings on Pyxis Ocean.
  • Average performance measured so far is within 10% of predictions made using computational fluid dynamics (CFD) simulations by BAR Technologies to estimate how well wind assisted propulsion would work on Cargill routes.
  • During optimal sailing conditions, the Pyxis Ocean achieved savings of more than 11t/day in fuel consumption, which translates to 41t/day less CO2e emitted well-to-wake, or a 37% emissions savings.
  • The 11.2t/day CO2e average above works out to be about 2650CO2e/yr (11.2t x 237 average sailing days per year = 2650t well-to-wake). This would be the equivalent of removing 480 cars off the road. (Reference: Greenhouse Gas Emissions from a Typical Passenger Vehicle | US EPA)
  • Cargill and MC Shipping have engaged DNV as an independent third party to review and verify the fuel savings calculations.

About WindWings

  • Cargill was the first to install “WindWings,” large solid wing sails with a potential to deliver double-digit percentage reductions in emissions.
  • Working with partner BAR Technologies, Cargill installed WindWings on a Kamsarmax vessel, Pyxis Ocean, that we are chartering from MC Shipping.
  • Installation was done at COSCO, in Shanghai, China in 2023.
  • Pyxis Ocean is now the most energy efficient Kamsarmax in Cargill’s fleet of chartered vessels
  • The Pyxis Ocean will be used to inform the potential scale-up across the fleet and industry. Cargill plans to continuously learn how to further improve design, operation, and performance.
  • The WindWing project is part of a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 955286

About Cargill Ocean Transportation

Cargill Ocean Transportation is a leading freight-trading organization that charters around 650 vessels worldwide at any one time. Founded in 1956 in Geneva, we benefit from the rich heritage and expert capabilities of Cargill’s global operations in food, agriculture and commodities trading. Our customers, including other companies as well as Cargill’s own internal businesses, are at the center of everything we do. We provide services that combine the latest digital technology with green solutions to make shipping safer and more sustainable.

About Cargill

Cargill is committed to providing food, ingredients, agricultural solutions, and industrial products to nourish the world in a safe, responsible, and sustainable way. Sitting at the heart of the supply chain, we partner with farmers and customers to source, make and deliver products that are vital for living.

Our 160,000 team members innovate with purpose, providing customers with life’s essentials so businesses can grow, communities prosper, and consumers live well. With 159 years of experience as a family company, we look ahead while remaining true to our values. We put people first. We reach higher. We do the right thing—today and for generations to come. For more information, visit Cargill.com and our News Center

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240313673847/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release

IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye